InvestorsHub Logo
Followers 0
Posts 48
Boards Moderated 0
Alias Born 11/28/2022

Re: hnbadger1 post# 408646

Monday, 03/27/2023 10:02:07 PM

Monday, March 27, 2023 10:02:07 PM

Post# of 466108
Interesting takes have been expressed as to why Jin joined AVXL

I can think of both positive and negative ones. Here's a positive one:
AVXL: Dr Jin, please review our phase 2b/3 data and tell us if you think it is good enough to get FDA approval
JIN: Odds of approval are slim to none
AVXL: Would you consider joining us and accepting a position where you get to design, implement and completely manage (including budget) a new phase 3 trial.
JIN: (after thinking about it for 5 seconds) Yes, sounds like a great opportunity.

Even if the new phase 3 trial doesn't meet endpoints, then adding this experience to his FDA background will qualify Jin for a CEO role at a biotech company. Excellent career choice for him.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News